| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000254205.1 |
AKT inhibitor VIII |
Lung squamous cell carcinoma |
0.041998898 |
Resistant |
| ENSG00000254205.1 |
AKT inhibitor VIII |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.002472159 |
Sensitive |
| ENSG00000254205.1 |
AKT inhibitor VIII |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012949576 |
Sensitive |
